[Catecholamines in the therapy of chronic cardiac insufficiency].
D002316:Cardiotonic Agents / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism / Q000627:therapeutic use*; D004280:Dobutamine / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D009200:Myocardial Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000627:therapeutic use; D011217:Practolol / Q000031:analogs & derivatives / Q000627:therapeutic use; D011294:Prenalterol; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
D002316:Cardiotonic Agents; D002395:Catecholamines; D011942:Receptors, Adrenergic, alpha; D004280:Dobutamine; D009921:Metaproterenol; D007545:Isoproterenol; D011294:Prenalterol; D011217:Practolol; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine
Katecholamine in der Therapie der chronischen Herzinsuffizienz.